Genelux (GNLX) Price to Book (2023 - 2026)
Genelux (GNLX) posted Price to Book of 4.73 for Q1 2026, down 67.13% on a QoQ basis from 14.4 in Q4 2025, and up 38.69% year-over-year from 3.41 in Q1 2025.
Analysis
Genelux (GNLX) Price to Book (2023 - 2026) Analysis & Trends
Genelux has reported Price to Book for 4 years, with the latest figure at 4.73 in Q1 2026.
- On a quarterly basis, Price to Book rose 38.69% year-over-year to 4.73 in Q1 2026; TTM through Mar 2026 was 4.73, a 38.69% increase from a year earlier, with the FY2025 full-year figure at 14.4, up 361.78% from the prior year.
- Price to Book was 4.73 for Q1 2026 at Genelux, down from 14.4 in the prior quarter.
- The five-year high for Price to Book was 27.17 in Q3 2023, with the low at 1.79 in Q2 2024.
- Average Price to Book over 4 years is 8.3, with a median of 4.53 recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Price to Book sank 90.9% in 2024, then jumped 361.78% in 2025.
- Over 4 years, Price to Book stood at 19.27 in 2023, then slumped by 83.82% to 3.12 in 2024, then surged by 361.78% to 14.4 in 2025, then sank by 67.13% to 4.73 in 2026.
- The last three Price to Book figures came in at 4.73 (Q1 2026), 14.4 (Q4 2025), and 8.6 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 4.73 |
| Dec 31, 2025 | 14.40 |
| Sep 30, 2025 | 8.60 |
| Jun 30, 2025 | 4.53 |
| Mar 31, 2025 | 3.41 |
| Dec 31, 2024 | 3.12 |
| Sep 30, 2024 | 2.47 |
| Jun 30, 2024 | 1.79 |
| Mar 31, 2024 | 11.51 |
| Dec 31, 2023 | 19.27 |
| Sep 30, 2023 | 27.17 |
| Jun 30, 2023 | 4.23 |
| Mar 31, 2023 | 2.72 |